Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Utah Medical Products, Inc. (Nasdaq: UTMD) announced a quarterly cash dividend of $.285 per share, payable on July 6, 2021, to shareholders of record as of June 15, 2021. This marks a 2% increase from the same quarter last year. The company specializes in developing, manufacturing, and marketing medical devices for women's healthcare and neonatal care, serving clinicians in over 100 countries worldwide.
Positive
- Dividend increased by 2% compared to the previous year.
- Quarterly cash dividend of $.285 per share enhances income for shareholders.
Negative
- None.
News Market Reaction – UTMD
In the trading session that priced this news, UTMD declined 0.13%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESSWIRE / May 11, 2021 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on July 6, 2021 to shareholders of record at the close of business on June 15, 2021. This is about a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Crystal Rios
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View source version on accesswire.com:
https://www.accesswire.com/646227/Utah-Medical-Products-Inc-Announces-Quarterly-Dividend